News

PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer

Sandra Tuyaerts, An M T Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys (2019) PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer BMC Cancer 28;19(1):506. doi: 10.1186/s12885-019-5676-3.

28 May 2019

Perioperative therapies - Using repurposed drugs to improve cancer surgery outcomes

Pan Pantziarka, PhD, Gauthier Bouche, MD (2019). Perioperative therapies - Using repurposed drugs to improve cancer surgery outcomes. The Cancer Journal 25(2):100-105. doi: 10.1097/PPO.0000000000000361

10 April 2019

Launch of the Anticancer Fund European Elections Manifesto 2019

9 April 2019

Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review.

A. SPINI, G. ROBERTO, R. GINI, C. BARTOLINI, L. BAZZANI, S. DONNINI, S. CRISPINO, M. ZICHE. Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review. Neoplasma 2019; 66(6): 963–970 963, doi:10.4149/neo_2019_190110N34

28 March 2019

Annual Impact Sheet 2018 published!

18 March 2019

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

Marie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, Julie Westerlin Kjeldsen, Magnus Pedersen, Christina Friese, Thomas Hasselager, Henrik Lajer, George Coukos, Michal Bassani-Sternberg, Marco Donia, Inge Marie Svane. Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer. British Journal of Cancer. 2019 Feb;120(4):424-434. doi: 10.1038/s41416-019-0384-y. Epub 2019 Feb 5.

5 February 2019